26396-84-9 Usage
Derivative of indazole
A heterocyclic compound containing a five-membered ring with two nitrogen atoms This compound is based on the indazole structure, which consists of a five-membered ring with two nitrogen atoms.
Tetrahydro derivative
Saturated ring with four carbon atoms and one nitrogen atom The compound has a fully saturated ring, meaning that it contains four carbon atoms and one nitrogen atom in the ring structure.
Potential applications
Pharmaceutical, organic synthesis, and material science This chemical may have possible uses in various fields, such as pharmaceuticals, organic synthesis, and material science.
Need for further research
Exploration of potential uses and properties More research is needed to fully understand the possible applications and properties of 1-methyl-4,5,6,7-tetrahydro-1H-indazol-3-amine.
Check Digit Verification of cas no
The CAS Registry Mumber 26396-84-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,3,9 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 26396-84:
(7*2)+(6*6)+(5*3)+(4*9)+(3*6)+(2*8)+(1*4)=139
139 % 10 = 9
So 26396-84-9 is a valid CAS Registry Number.
26396-84-9Relevant articles and documents
9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS
-
Paragraph 0583, (2015/09/28)
The present disclosure provides substituted 9H-pyrimido[4,5-b]indoles and 5H-pyrido[4,3-b]indoles and related analogs represented by Formula I: and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R1a, A, B1, B2, G, X1, Y1, Y2, and Y3 are as defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a condition or disorder responsive to inhibition of BET bromodomains. Compounds of the present disclosure are especially useful for treating cancer.
